Adapsyn Bioscience is a owner and operator of a biotechnology company intended to focus on the identification and characterization of microorganism-derived small molecules, to uncover chemical agents possessing novel biological activities relevant to the biotechnology and pharmaceutical sectors. The company's services is supported bycutting-edge bioinformatic software platforms and state of the art laboratory facilities, enabling researchers to drive the discovery of a diversified portfolio of drugs, thereby expediting the search for medicines that will better protect users from a wide spectrum of diseases.

Biotechnology

Health Data

Adapsyn Bioscience

David Earl

Nathan Magarvey

Christopher O’Donnell

Kelly Holman

Lloyd Mackenzie

This department oversees the strategic direction and governance of the organization.

Executive Leadership

The Scientific Research Team at Adapsyn Bioscience focuses on the discovery and analysis of microorganism-derived small molecules with potential pharmaceutical applications. Leveraging state-of-the-art bioinformatic software and advanced laboratory facilities, the team collaborates to identify and characterize novel chemical agents. Under the leadership of directors specializing in chemical biology, analytical chemistry, and microbiology, alongside the expertise of a natural product microbiologist, the team aims to expedite the development of groundbreaking drugs to treat a wide spectrum of diseases.

Scientific Research Team

This department oversees the strategic direction and operational effectiveness of technology initiatives.

Adapsyn Bioscience

Org chart

Board & advisors

Teams

Executive Leadership

Scientific Research Team

Technology Management

Offices

Adapsyn Bioscience

Org chart

Board & advisors

Teams

Executive Leadership

Scientific Research Team

Technology Management

Offices

Related companies